Tilray Brands Inc TLRY

Tilray Brands - American Cannabis Update

[DaveInCalgary]

Tilray Sees Cannabis Rescheduling as
Gateway to U.S. Medical Market

 

Dean Seal, Dow Jones Newswire Jan. 10, 2024 at 7:32 PM EST 

 

Tilray Brands believes it can get into the medical marijuana
business
in the U.S. pretty quickly if the Biden administration reclassifies
cannabis as a Schedule 3 drug sometime this year,
CEO Irwin Simon tells WSJ.

As one of the largest medical cannabis businesses in both
Canada and Europe, Tilray has "the expertise in growth, the
research and the
know-how" to launch medical cannabis operations in the U.S. expeditiously, whether through a greenfield approach or by
acquiring an existing player in the States, Simon says.

The CEO says Tilray would target the big markets on both coasts,
including California and New York.

[Ventura2020]

Along with Aurora and Tilray. Nobody knows the ins and outs of Medicinal Cannabis like them. Ownly the best from this group and way ahead of the game  of most, when it comes to Medical Cannabis.  European's demand it, well known as only the best from from Canada   Good post, Dave!